Pembrolizumab in Patients With Poor-Prognosis Carcinoma of Unknown Primary Site (CUP)

Condition:   Carcinoma of Unknown Primary Intervention:   Drug: Pembrolizumab Injection Sponsor:   AHS Cancer Control Alberta Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials